| Autor: |
Evans, William J., Kotler, Donald P., Staszewski, Schlomo, Griffin, George E., Isgaard, Jorgen, Gertner, Joseph M., O'Brien, Fanny, Svanberg, Elisabeth |
| Zdroj: |
AIDS Reader; Jun2005, Vol. 15 Issue 6, p301-314, 8p, 3 Charts, 3 Graphs |
| Abstrakt: |
Over 700 patients with HIV-associated wasting while receiving HAART were randomly assigned to double-blind treatment for 12 weeks with recombinant human growth hormone (rhGH) daily or on alternate days, or to placebo. Maximum exercise intensity increased by a median of 2.35 kJ in the alternate-days group and 2.60 kJ in the daily group but decreased by 0.25 kJ in the placebo group. The median difference between the daily and placebo groups was 2.85 kJ (P < .0001). These improvements suggest that rhGH treatment may enable patients with wasting to perform activities of daily living that would be exhausting without rhGH treatment. [AIDS Reader. 2005;15:301-303, 306-310, 314] [ABSTRACT FROM AUTHOR] |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
